The Pathology Core will provide coordination for all pathology activities within the program project including histologic, morphometric, immunologic and molecular analysis of tissue. This will reduce duplication of effort among the different projects and allow a degree of expertise that would be difficult to achieve in any single project. Along with the technical advantages of a single morphologic core, the use of a single principal pathologist will also promote uniform analysis of results allowing more ready comparison among the projects. Furthermore, by providing uniform access to specialized morphologic techniques, this facility will form a focal point for collaboration among members of the grant. Technical services provided include routine paraffin embedded histology, electron microscopy, immunohistochemical stains on frozen and paraffin embedded tissue, and in situ analysis for mRNA. The results will be analyzed by a pulmonary pathologist for nature and extent of inflammatory change, microanatomic location of the infiltrate, presence of airway or other tissue remodeling, and presence of epithelial injury. Any changes identified will be quantified by morphometry where appropriate. The core director has successfully served as director for a previous asthma SCOR grant. He thus has a full working relationship with all current program project members. Furthermore, due to this previous experience, the Core has achieved a level of excellence that would have been difficult to achieve in any other environment and will be difficult to continue in the absence of program project support.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL056389-09
Application #
7025773
Study Section
Project Start
Project End
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
9
Fiscal Year
2005
Total Cost
$298,777
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Liu, Juan; Harberts, Erin; Tammaro, Antonella et al. (2014) IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 134:1903-1911
Bhandari, Vineet; Choo-Wing, Rayman; Harijith, Anantha et al. (2012) Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol 46:668-76
Homer, Robert J; Elias, Jack A; Lee, Chun Gun et al. (2011) Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 135:780-8
Koh, Byung Hee; Hwang, Soo Seok; Kim, Joo Young et al. (2010) Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma. Proc Natl Acad Sci U S A 107:10614-9
Chapoval, Svetlana P; Lee, Chun Geun; Tang, Chuyan et al. (2009) Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. Clin Immunol 132:371-84
Hartl, Dominik; He, Chuan Hua; Koller, Barbara et al. (2008) Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J Biol Chem 283:33472-82
He, Chuan Hua; Waxman, Aaron B; Lee, Chun Geun et al. (2005) Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest 115:1039-48
Becker, Patrice M; Waltenberger, Johannes; Yachechko, Robin et al. (2005) Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. Circ Res 96:1257-65
Wisnewski, Adam V; Liu, Qing; Miller, Jing-Jing et al. (2002) Effects of hexamethylene diisocyanate exposure on human airway epithelial cells: in vitro cellular and molecular studies. Environ Health Perspect 110:901-7
Wisnewski, A V; Cain, H; Magoski, N et al. (2001) Human gamma/delta T-cell lines derived from airway biopsies. Am J Respir Cell Mol Biol 24:332-8

Showing the most recent 10 out of 13 publications